welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
How Patient Groups have Begun to Influence the Value and Coverage Debate
source: Health Affairs Blog
year: 2016
authors: Margaret Anderson, Kristin Schneeman
summary/abstract:In 2015, two issues related to medicine could be relied on to generate headlines: drug pricing and the proliferation of new value frameworks that claimed to define the value and even the price of drugs in seemingly easy-to-understand ways. In none of the high-profile skirmishes on pricing or frameworks was the voice or perspective of patients and patient groups very much in evidence. But that is beginning to change, in an evolution of a broader shift in the role that patients are playing in the research and development (R&D) enterprise.
read moreexpertly curated content related to this topic
-
Karen Hurley, PhDI am a licensed clinical psychologist sp...
-
The Gastrointestinal Cancer Risk and Prevention ClinicThe Gastrointestinal Cancer Risk and Pre...
-
Matthew G. Mutch, MDMatthew G. Mutch, MD, is a Professor in ...
-
Deborah I. Barragan, MS, CGCGenetic Counselor Education: MS, Human G...
-
OHSU Knight Cancer InstituteDriven by its mission to end cancer, OHS...
-
Lori L. Ballinger, MSGenetic Counselor Skills and Expert...
-
Ann Bastian, MSGenetic Counselor She worked as a gen...